Mucocutaneous Lymph Node Syndrome

"Mucocutaneous Lymph Node Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.

Descriptor ID	D009080
MeSH Number(s)	C14.907.940.560 C15.604.560 C17.800.862.560
Concept/Terms	Mucocutaneous Lymph Node Syndrome Mucocutaneous Lymph Node Syndrome Kawasaki Syndrome Lymph Node Syndrome, Mucocutaneous Kawasaki Disease

Below are MeSH descriptors whose meaning is more general than "Mucocutaneous Lymph Node Syndrome".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Vasculitis [C14.907.940]
Mucocutaneous Lymph Node Syndrome [C14.907.940.560]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Mucocutaneous Lymph Node Syndrome [C15.604.560]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Diseases, Vascular [C17.800.862]
Mucocutaneous Lymph Node Syndrome [C17.800.862.560]

Below are MeSH descriptors whose meaning is related to "Mucocutaneous Lymph Node Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Mucocutaneous Lymph Node Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mucocutaneous Lymph Node Syndrome" by people in this website by year, and whether "Mucocutaneous Lymph Node Syndrome" was a major or minor topic of these publications.

Bar chart showing 16 publications over 13 distinct years, with a maximum of 2 publications in 2003 and 2005 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Total
1999	1	1
2000	1	1
2003	2	2
2005	2	2
2008	1	1
2010	1	1
2011	1	1
2012	1	1
2013	1	1
2017	1	1
2019	1	1
2020	1	1
2021	2	2

Below are the most recent publications written about "Mucocutaneous Lymph Node Syndrome" by people in Profiles.

Burney JA, DeHaan LL, Shimizu C, Bainto EV, Newburger JW, DeBiasi RL, Dominguez SR, Portman MA, Melish M, Bratincsak A, Fabi M, Corinaldesi E, Yu JJ, Gee P, Kitano N, Tremoulet AH, Cayan DR, Burns JC. Temporal clustering of Kawasaki disease cases around the world. Sci Rep. 2021 11 19; 11(1):22584.

View in: PubMed
Porritt RA, Chase Huizar C, Dick EJ, Kumar S, Escalona R, Gomez AC, Marek-Iannucci S, Noval Rivas M, Patterson J, Forsthuber TG, Arditi M, Gorelik M. Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis. Front Immunol. 2021; 12:630196.

View in: PubMed
Dawson TJ, Vuong CT, Ma SCY, Russell CR, Melish ME, Bratincsak A. Mapping the Trends of Kawasaki Disease in Hawai'i from 1996 to 2018. Hawaii J Health Soc Welf. 2020 05 01; 79(5 Suppl 1):104-111.

View in: PubMed
Ma S, Choi SY, Ahn HJ, Siu AM, Melish ME, Bratincsak A. The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease. J Pediatr. 2020 03; 218:72-77.e1.

View in: PubMed
Bratincsak A, Limm-Chan BN, Nerurkar VR, Ching LL, Reddy VD, Lim E, Shohet RV, Melish ME. Study design and rationale to assess Doxycycline Efficacy in preventing coronary Artery Lesions in children with Kawasaki disease (DEAL trial) - A phase II clinical trial. Contemp Clin Trials. 2018 02; 65:33-38.

View in: PubMed
Garnett GM, Kimball S, Melish ME, Thompson KS, Puapong DP, Johnson SM, Woo RK. Appendicitis as the presenting manifestation of Kawasaki disease. Pediatr Surg Int. 2014 May; 30(5):549-52.

View in: PubMed
Tremoulet AH, Pancoast P, Franco A, Bujold M, Shimizu C, Onouchi Y, Tamamoto A, Erdem G, Dodd D, Burns JC. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012 Sep; 161(3):506-512.e1.

View in: PubMed
Sachdeva R, Eble BK. Rapid progression of coronary aneurysm to stenosis in a patient with Kawasaki disease. J Invasive Cardiol. 2012 Jan; 24(1):36-7.

View in: PubMed
Rod? X, Ballester J, Cayan D, Melish ME, Nakamura Y, Uehara R, Burns JC. Association of Kawasaki disease with tropospheric wind patterns. Sci Rep. 2011; 1:152.

View in: PubMed
Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J. 2010 Aug; 69(8):194-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals